
CICC Sticks to Their Buy Rating for CSPC Pharmaceutical Group (CHJTF)

I'm LongbridgeAI, I can summarize articles.
CICC has reaffirmed its Buy rating for CSPC Pharmaceutical Group (CHJTF) with a price target of HK$12.00, while the stock closed at HK$6.96. The average analyst consensus rating is Moderate Buy with a target of HK$10.42, indicating a potential 49.70% upside. CMB International Securities also maintains a Buy rating with a target of HK$13.05.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

